Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

BiferaRx

Last reviewed on RxList: 11/8/2018
Drug Description

BIFERARX
(folic acid, heme iron polypeptide, iron dextran, and cyanocobalamin) Tablets/p>

DESCRIPTION

BiferaRx™ is a prescription iron supplement. BiferaRx™ is a small oval, film-coated maroon tablet, with black core, debossed and bisected with "AP|85" on one side, and plain on the other.

Each BiferaRx™ tablet contains:

Vitamins

Amount per serving:

Folic Acid 1 mg
B12 (as cyanocobalamin) 25 mcg

Minerals

Iron as PIC (polysaccharide iron complex) 22 mg
as HIP (heme iron polypeptide as Proferrin - bovine source, USDA certified) 6 mg

Inactive Ingredients

Microcrystalline cellulose, croscarmellose sodium, crospovidone, magnesium stearate, silicon dioxide, coating (polyvinyl alcohol, polyethylene glycol, talc, FD&C red no. 40 aluminum lake, titanium
dioxide, FD&C blue no. 2 aluminum lake).

Indications & Dosage

INDICATIONS

BiferaRx™ is a prescription iron supplement indicated for use in improving the nutritional status of iron deficiency.

DOSAGE AND ADMINISTRATION

One tablet daily with or without food or as prescribed by a licensed healthcare provider with prescribing authority.

HOW SUPPLIED

BiferaRx™ tablets are supplied in child-resistant bottles of 90 tablets (NDC 68220-085-90) and as a Professional Sample 5 tablet blister pack (NDC 68220-085-25).

KEEP OUT OF REACH OF CHILDREN.

Storage

Store at controlled room temperature 20°-25°C (68°-77°F). Excursions permitted to 15°-30°C (59°- 86°F). [See current USP]

Dispense in a tight, light-resistant container to protect from light and moisture.

For medical inquiries call toll free 1-888-317-0001. www.BiferaRx.com. Manufactured for: ALAVEN PHARMACEUTICAL LLC, Marietta, GA 30062.Revised: Mar 2010

QUESTION

Sickle cell disease is named after a farming tool. See Answer
Side Effects & Drug Interactions

SIDE EFFECTS

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

DRUG INTERACTIONS

No information provided.

Warnings & Precautions

WARNINGS

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6.

Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS

Folic acid when administered as a single agent in doses above 0.1mg daily may obscure pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive. While prescribing this nutritional supplement for pregnant women, nursing mothers, or for women prior to conception, their medical condition and other drugs, herbs, and/or supplements consumption should be considered.

Overdosage & Contraindications

OVERDOSE

No information provided.

CONTRAINDICATIONS

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Hemochromatosis and hemosiderosis are contraindications to iron therapy.

Clinical Pharmacology

CLINICAL PHARMACOLOGY

No information provided.

Medication Guide

PATIENT INFORMATION

No information provided. Please refer to the WARNINGS and PRECAUTIONS sections.

FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Health Solutions From Our Sponsors

CONTINUE SCROLLING FOR RELATED SLIDESHOW